다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

SVA

Sinovac Biotech (SVA)

Sinovac Biotech Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SVA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/28	21:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2025/02/28	21:00	Business Wire	SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order	NASDAQ:SVA	Sinovac Biotech Ltd
2025/02/20	06:01	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2025/01/16	22:48	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2025/01/16	22:01	Business Wire	SINOVAC Issues Statement Regarding Privy Council Judgment	NASDAQ:SVA	Sinovac Biotech Ltd
2024/12/17	22:06	Business Wire	シノバック、手足口病（HFMD）に対する2価ワクチンの第III相臨床試験を開始	NASDAQ:SVA	Sinovac Biotech Ltd
2024/12/17	22:04	Business Wire	SINOVAC hat eine klinische Phase-III-Studie zu einem bivalenten Impfstoff gegen Hand-Fuß-Mund-Krankheit (HFMD) initiiert	NASDAQ:SVA	Sinovac Biotech Ltd
2024/12/17	22:02	Business Wire	SINOVAC a lancé un essai clinique de Phase III sur un vaccin bivalent contre la maladie mains-pieds-bouche (MMPB)	NASDAQ:SVA	Sinovac Biotech Ltd
2024/12/16	19:04	Business Wire	SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)	NASDAQ:SVA	Sinovac Biotech Ltd
2024/09/13	05:03	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/08/17	05:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/08/16	21:54	Business Wire	SINOVAC Reports Unaudited First Half of 2024 Financial Results	NASDAQ:SVA	Sinovac Biotech Ltd
2024/06/18	05:02	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/04/30	06:53	Business Wire	SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/21	20:09	Edgar (US Regulatory)	Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/21	20:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/21	16:56	Business Wire	Sinovac Amends Shareholder Rights Plan	NASDAQ:SVA	Sinovac Biotech Ltd
2024/02/03	01:19	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	20:58	Business Wire	シノバック取締役会、一方的な部分公開買い付けを全会一致で退ける	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	04:54	Business Wire	Sinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	04:47	Business Wire	Le conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitée	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/19	03:33	Business Wire	Das Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot ab	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/18	21:13	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/18	21:00	Business Wire	Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	NASDAQ:SVA	Sinovac Biotech Ltd
2024/01/09	06:46	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:SVA	Sinovac Biotech Ltd
2023/12/04	20:01	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/10/03	22:39	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/15	21:59	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/12	19:10	Business Wire	シノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告	NASDAQ:SVA	Sinovac Biotech Ltd
2023/09/11	23:36	Business Wire	SINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 Injection	NASDAQ:SVA	Sinovac Biotech Ltd

검색 관련기사 보기:NASDAQ:SVA

1 2 3 4 5 6 7 8 9 10 다음 >>

Sandy Spring Bancorp

Bank of Montreal

BNP Paribas Arbitrage Is...

Vontobel Financial Produ...

Bnp Paribas Issuance

iShares iBonds Dec 2044 ...

Diamond Offshore Drilling

Intesa Sanpaolo

Montrose Environmental

Vontobel Financial Produ...

Intesa Sanpaolo

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관